Cargando…
Glycosaminoglycan Storage Disorders: A Review
Impaired degradation of glycosaminoglycans (GAGs) with consequent intralysosomal accumulation of undegraded products causes a group of lysosomal storage disorders known as mucopolysaccharidoses (MPSs). Characteristically, MPSs are recognized by increased excretion in urine of partially degraded GAGs...
Autores principales: | Coutinho, Maria Francisca, Lacerda, Lúcia, Alves, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195295/ https://www.ncbi.nlm.nih.gov/pubmed/22013531 http://dx.doi.org/10.1155/2012/471325 |
Ejemplares similares
-
Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders
por: Coutinho, Maria Francisca, et al.
Publicado: (2016) -
Genetic Substrate Reduction Therapy: A Promising Approach for Lysosomal Storage Disorders
por: Coutinho, Maria Francisca, et al.
Publicado: (2016) -
Splicing Modulation as a Promising Therapeutic Strategy for Lysosomal Storage Disorders: The Mucopolysaccharidoses Example
por: Santos, Juliana Inês, et al.
Publicado: (2022) -
Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation
por: Morla, Shravan
Publicado: (2019) -
Synthetic genistein derivatives as modulators of glycosaminoglycan storage
por: Kloska, Anna, et al.
Publicado: (2012)